For two decades, data from human studies and transgenic animal Until recently, with the exception of the artificial G86R and G93R 59 mutations created in mouse and zebrafish SOD1, respectively, humans 60 were the only organisms in which ALS occurred, and the only organisms 61 where mutations in SOD1 responsible for causing this disease have been 62 described (Ramesh et al., 2010; Ripps et al., 1995) . That changed with 63 GWAS data linking a mutation in canine SOD1 (cSOD1) to canine of the disease can last as long as 3 years (Coates and Wininger, 2010) .
75
Histopathology of spinal cords from affected dogs show a similar pattern 76 of myelin and axonal loss replaced with astrogliosis seen in human ALS, 77 and immunohistochemistry reveals the same SOD1 aggregates in motor 78 neurons that are present in humans and rodent models with human 79 SOD1 (hSOD1) mutations (Awano et al., 2009; Bruijn, 1998 PBS, centrifuged again, and frozen until needed for purification.
192
Cell pellets were thawed on ice and resuspended in lysis buffer
193
(10 mM Tris, 1 mM EDTA, 150 mM NaCl, 1% Triton X-100, and 5 mM
194
DTT, pH 8.0). Cells were incubated with 4 mg/mL lysozyme (Sigma)
for 15 min at room temperature, followed by sonication and centrifuga- (Borchelt et al., 1994) . As 315 predicted from the structural location of these mutants (i.e. outside
of the metal binding region), both cSOD1 mutants retain full enzy-317 matic activity (Fig. 3A) , providing evidence in favor of a toxic gain 318 of function in dogs homozygous for these mutations.
319
Since both canine mutants were dismutase active, we predicted that with its greater degree of aggregation in cell culture (Fig. 5A ).
348
To visualize the degree of aggregation of cSOD1 mutants, we tagged sion levels resulted in significant aggregation in 10-20% of cells for Fig. 1 . Canine DM spinal cords contain detergent-insoluble SOD1 that correlates with disease severity. Detergent extraction of cSOD1 from thoracic spinal cord sections of non-affected dogs (Ctrl) and DM-affected dogs of increasing disease severity (Grades 1-4, with Grade 1 mild and Grade 4 severe) shows increasing levels of detergent-insoluble mutant SOD1 (P2 fraction) with increasing DM Grade. Age is indicated in parentheses. As controls, transgenic rats overexpressing hSOD1 WT or SOD1 G93A were included. The S1 lanes contain 16 μg protein, except for the transgenic rat samples at 4 μg, and the P2 lanes contain 18.6 μg protein. 
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ΔHydrophobicity calculated according to Chiti et al. (2003) . (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)
both mutants, while the WT protein remained soluble (Fig. 5) . Data
354
show that the degree of aggregation for the E40K mutant was signifi-355 cantly more than the T18S mutant, which reflects its increased aggrega- ists (Turner and Talbot, 2008) . To address any biochemical overlap 366 between this mutation in humans and dogs, we created the E40K mu-367 tation in hSOD1 via site directed mutagenesis. As the location of this 368 mutation in both human and canine SOD1 falls within one of the 369 connecting loops and does not interfere with metal binding, we pre-370 dicted that the human E40K mutant would, like its canine counter-371 part, be an enzymatically active dimer. A partially denaturing PAGE 372 gel and dismutase activity confirm these predictions (Figs. 6A,B) .
373
However, when we transiently transfected human SOD1 E40K into 374 NSC34 cells, no aggregates were observed, even up to 72 h after 375 transfection (Fig. 6C and data not shown) . This is despite ample 376 YFP-cSOD1 protein production in cells by Western blot (Fig. 6D) .
377
To rule out any inhibitory effects that the YFP tag may have on aggre-378 gation, we transiently-transfected untagged hSOD1 WT, G85R, and 379 E40K, as well as cSOD1 WT, E40K, and T18S, into NSC34 cells and 380 looked for the presence of aggregates via a filter trap assay (Fig. 6E) .
381
In agreement with previous observations with YFP-tagged SOD1 382 constructs, we found a significant aggregation signal from canine 383 E40K and T18S and human G85R, but not human E40K. We subse-384 quently created the hSOD1 E40G mutation to see if the lack of aggre-385 gation in human E40K was amino acid specific, but also found no 386 aggregation in NSC34 or HEK293 cells (data not shown). Thus, despite 387 the high sequence similarity between species, the aggregation pro-388 pensity of the E40K mutation is unique to cSOD1 under the conditions 389 and with the cell types studied here.
390

Discussion and conclusions
391
The discovery that mutations in SOD1 are linked to canine DM translate into impaired performance on motor tests (Flood et al., 416 1999; Kostrominova, 2010; Muller et al., 2006; Shefner et al., 1999) .
417
Therefore, we first needed to rule out SOD1 loss of function in these 418 animals. As our data show that the canine E40K and T18S mutations 419 form enzymatically active dimers, we are confident that the canine 
cSOD1, the E40K mutation occurs at a conserved residue between 459 canine and human SOD1. When we created the E40K mutation in 460 hSOD1 to explore the similarities with the canine mutant, we showed 461 that this mutation, like canine E40K, is a dismutase active dimer.
462
However, we were surprised to find that mutating this residue in 463 hSOD1 does not result in an aggregation phenotype despite the 
prevalent aggregation seen in its canine counterpart and despite the 465 appearance of an hSOD1 E40G mutation in the SOD1 literature 466 (Turner and Talbot, 2008 Coates et al., 2007; Shelton et al., 2012) . Despite these differ- 
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